Search results for "clinical trials":

Blog Posts - 48 item(s) found

• From Past to Present: Honoring Clinical Trials Day and Advancing Breast Cancer Care

  Since 2014, May 20th has been promoted as Clinical Trials Day by the Association of Clinical Research Professionals. It is a moment to recognize the pivotal role clinical trials play in advancing research and treatment for many diseases, including breast cancer. This day was chosen to honour Scottish surgeon James…

• Q&E Sessions: A Surgical Oncologist Answers Your Questions About Breast Cancer Clinical Trials

  In today’s post, we provide the questions that were sent in and asked during the live session of our Questions and Experts session held on October 3, 2023. In this session, Surgical Oncologist Dr. Mark Basik answers your questions about clinical trials. In the parentheses, you’ll find the timestamp of…

• Metastatic Breast Cancer: The Latest Research and Clinical Trials

  Research on breast cancer, and more specifically, metastatic breast cancer (mBC), is critical in helping us better understand this disease. While widespread knowledge of mBC is still limited, there are studies that look specifically at the detection, prognosis and treatment of this type of breast cancer. Similarly, clinical trials on…

• 5 Clinical Trials Currently Recruiting Across Canada

  Each year, May 20th is recognized as Clinical Trials Day across the globe. In honor of this, we are highlighting various multi-centre clinical trials that are currently recruiting participants. Clinical trials are important for the advancement of cancer treatment and care, as well as important in improving the standard-of-care.

• What you need to know: Accessing clinical trials out of province and out of country

  I have been living with metastatic breast cancer for over eight years. While I am usually averse to using battle analogies for living with and dying from cancer, finding the best care has required a fight, considerable perseverance, and hard work. Fortunately, my ER+/PR+ tumours (pleura/liver/lymph) have responded well, but…

• Clinical Trials Part 3: Clinical Trials That Don’t Involve Testing Drugs

  In part 1 of our clinical trials series, we explained that clinical trials allow doctors and researchers to test treatments, medical procedures and therapies for various diseases and conditions. In the second part of the series, we debunked 7 common myths on clinical trials. In both parts, we focused on…

• Clinical Trials Part 2: Debunking Common Myths About Clinical Trials

  In part 1 of our blog series on clinical trials, we explained what clinical trials are, why you should participate in them and how to get more information about participating. You may now be familiar with clinical trials but still hesitant about enrolling in one because of certain concerns that…

• Clinical Trials Series Part 1: What Are Clinical Trials and Are They Right for Me?

  According to a 2014 study by the Canadian Partnership Against Cancer, less than 7% of adult cancer patients enrolled in clinical trials.1 This may be because many cancer patients are not aware of clinical trials, do not know how to enroll in them or are concerned that they are unsafe. In…

• New clinical trials finder helps you find a trial

  Are you looking for a clinical trial but not sure how to start or where to go? A new Clinical Trials Finder has been developed by Clinical Trials Ontario (CTO) to help you. You can search for a clinical trial in any province or territory in Canada, using only a…

• Clinical Trials in Canada: What’s currently being offered in breast cancer? - Early Stage

• Clinical Trials – 101

  Clinical trials play a big role in the discovery of new treatments for cancer. They help to determine the safety and effectiveness of potential new treatments. For metastatic patients, they can also potentially offer additional treatment options after the cancer has grown resistant to the standards of care.

• Clinical Trials in Canada: What’s currently being offered in breast cancer? - Metastatic

• Understanding Common Research Terms

  Have you ever found yourself confused and wondering what all those scientific terms mean in the research studies we share on breast cancer? If so, we’ve compiled a list of common terms used in various breast cancer news articles to help explain how they are used in determining the results…

• The Importance of EDI in Precision Medicine

  As we mark Precision Medicine Awareness Month (PMAM) this #KNOWvember, it's crucial to highlight the essential need for equity, diversity, and inclusion (EDI) in the rapidly advancing field of precision medicine.

• Immunotherapy and Breast Cancer Explained: Thoughts From a Researcher Who Has Also Had Triple Negative Breast Cancer

  Traditional cancer therapies (such as chemotherapy and radiation therapy) have shown widespread success against various cancer types, but are known to have toxic, undesirable side effects as they do not selectively kill cancer cells and therefore actively damage healthy cells as well. This is where immunotherapy comes into play. Immunotherapy…

• What Canadian Oncology Experts are Recommending to Improve Access to New Cancer Treatments

  The world of cancer treatment is rapidly advancing. Scientists are discovering new ways to target cancers, making drugs more effective and more precise. But with these new advancements, comes a long process of approvals involving many steps to allow Canadians to access them. Not only do new drugs need to…

• Questions and Experts Session Guide: A Medical Oncologist Answers Questions about Triple Negative Breast Cancer

  A breast cancer diagnosis comes with so many questions and there never seems to be enough time at appointments to have some of these questions answered. To help address this, we developed a "Q&E: Questions and Experts" series. In this series, a variety of experts spend the entire virtual session answering pre-submitted…

• Questions and Experts Session Guide: A Medical Oncologist Answers Questions about HR-Positive Breast Cancer

  In today’s post, we provide the questions that were sent in and asked during the live session of our Questions and Experts session held in April 2021. In this session, Dr. Sandeep Sehdev, MD, FRCPC, a Medical Oncologist, answered questions about HR-positive breast cancer. In the parentheses, you’ll find the…

• TNBC: Who’s at Risk?

  Treatment can be difficult for this type of breast cancer. Without receptors, triple negative tumors do not have the proteins they need to respond to common breast cancer treatments like hormone and targeted therapy, which are used for hormone-positive or HER2-positive breast cancer. Research shows that some people have a…

• Fear of recurrence runs high for triple negative breast cancer patient

  Montreal resident Kelina feels like a “sitting duck” because although researchers are working hard to find treatments for triple negative breast cancer, there are no targeted therapies available to this cancer, which was diagnosed in December 2015.